NantKwest, Inc. Uncategorized Contracts & Agreements

29 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Registrants Securities
NantKwest, Inc.
Biotechnology
2024
Letter of Amendment dated
NantKwest, Inc.
Biotechnology
2023
Letter of Amendment dated
NantKwest, Inc.
Biotechnology
2023
Letter of Amendment dated
NantKwest, Inc.
Biotechnology
2023
Letter of Amendment dated
NantKwest, Inc.
Biotechnology
2023
Letter of Amendment dated
NantKwest, Inc.
Biotechnology
2023
Offer Letter, dated October 12, 2021, by and among ImmunityBio, Inc. and Regan Lauer
NantKwest, Inc.
Biotechnology
2022
Description of Registrants Securities
NantKwest, Inc.
Biotechnology
2022
Open Market Sale Agreement dated April 30, 2021, by and between ImmunityBio, Inc. and Jefferies LLC
NantKwest, Inc.
Biotechnology
NY
2021
Offer Letter, dated August 3, 2020, by and among ImmunityBio, Inc. and David Sachs
NantKwest, Inc.
Biotechnology
2021
Letter Agreement, dated February 14, 2018, by and between NantPharma, LLC and Immunotherapy NANTibody, LLC
NantKwest, Inc.
Biotechnology
DE
2021
FDA Milestone Contingent Value Rights Agreement, dated July 31, 2017, by and between ImmunityBio, Inc. and the Stockholder Representative thereunder
NantKwest, Inc.
Biotechnology
DE
2021
Offer Letter between the Company and Richard Adcock, dated October 26, 2020
NantKwest, Inc.
Biotechnology
2020
First Amendment to the July 1, 2019 Letter Agreement between the Company and Immuno-Oncology Clinic, Inc., dated March 31, 2020
NantKwest, Inc.
Biotechnology
2020
Cost Allocation Agreement between the Company and ImmunityBio, Inc. and its subsidiaries, dated January 29, 2020
NantKwest, Inc.
Biotechnology
CA
2020
Description of the Registrants Securities
NantKwest, Inc.
Biotechnology
2020
Letter Agreement between the Company and Immuno-Oncology Clinic, Inc., dated July 5, 2019
NantKwest, Inc.
Biotechnology
CA
2019
Letter Agreement with Barry Simon dated May 3, 2018
NantKwest, Inc.
Biotechnology
2018
NantKwest Inc. | 9920 Jefferson Blvd, Culver City, CA 90232 www.nantkwest.com
NantKwest, Inc.
Biotechnology
2016
3530 John Hopkins Court, San Diego, CA 92121 Main: (858) 633-0300 Fax: (858) 380-1999 www.NantKwest.com
NantKwest, Inc.
Biotechnology
CA
2016
LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND HANS G. KLINGEMANN
NantKwest, Inc.
Biotechnology
IL
2015
LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND HANS G. KLINGEMANN
NantKwest, Inc.
Biotechnology
IL
2015
LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND FOX CHASE CANCER CENTER
NantKwest, Inc.
Biotechnology
IL
2015
LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND HANS G. KLINGEMANN
NantKwest, Inc.
Biotechnology
IL
2015
LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND FOX CHASE CANCER CENTER
NantKwest, Inc.
Biotechnology
IL
2015
AGREEMENT
NantKwest, Inc.
Biotechnology
DE
2015
AGREEMENT
NantKwest, Inc.
Biotechnology
DE
2015
CONKWEST, INC. 2014 EQUITYINCENTIVE PLAN
NantKwest, Inc.
Biotechnology
DE
2015
CONKWEST, INC. 2533 SouthCoast Highway 101, Suite 210 Cardiff by the Sea, CA 92007 June 18, 2015
NantKwest, Inc.
Biotechnology
CA
2015